ATEA PHARMACEUTICALS, INC.

(AVIR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 3 452743604--
Enterprise Value (EV)1 2 602-21,411,4-139-243
P/E ratio -81,9x6,53x-3,30x-2,84x7,67x
Yield -----
Capitalization / Revenue 71,0x2,11x-4,19x1,56x
EV / Revenue 53,5x-0,06x--0,97x-0,63x
EV / EBITDA -236x-0,15x-0,06x2,88x-1,44x
Price to Book 1,65x1,05x1,12x1,19x0,91x
Nbr of stocks (in thousands) 82 61783 10383 258--
Reference price (USD) 41,88,947,257,257,25
Announcement Date 03/30/202102/28/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 -48,6351-144386
EBITDA1 --11,0138-181-48,3169
Operating profit (EBIT)1 --11,0138-179-96,7169
Operating Margin --22,7%39,4%--67,2%43,7%
Pre-Tax Profit (EBT)1 --10,9139-191-227253
Net income1 -14,0-10,9121-183-21484,3
Net margin --22,5%34,5%--149%21,8%
EPS2 -1,39-0,511,37-2,20-2,560,94
Dividend per Share ------
Announcement Date 06/19/202003/30/202102/28/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 32,8192----
EBITDA1 -22,1121-42,2-47,0-55,0-62,0
Operating profit (EBIT)1 -22,1121-42,2-45,1-50,1-54,1
Operating Margin -67,5%63,1%----
Pre-Tax Profit (EBT)1 -22,1121-42,1-45,1-50,1-54,1
Net income1 -28,2117-42,1-43,4-47,1-50,5
Net margin -85,9%60,9%----
EPS2 -0,341,32-0,51-0,52-0,56-0,60
Dividend per Share ------
Announcement Date 11/11/202102/28/202205/10/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 -850764592743847
Leverage (Debt / EBITDA) -77,2x-5,52x3,27x15,4x-5,00x
Free Cash Flow1 -297-87,0-202-202277
ROE (Net Profit / Equities) --4,39%19,3%-28,3%-18,9%31,6%
Shareholders' equity1 -2496296471 136266
ROA (Net Profit / Asset) --2,47%14,8%-30,7%-55,3%42,2%
Assets1 -443818597388200
Book Value Per Share2 -25,48,546,476,108,00
Cash Flow per Share ------
Capex ------
Capex / Sales ------
Announcement Date 06/19/202003/30/202102/28/2022---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (USD) 603 617 534
Net sales (USD) 351 367 000
Number of employees 64
Sales / Employee (USD) 5 490 109
Free-Float 89,5%
Free-Float capitalization (USD) 540 102 546
Avg. Exchange 20 sessions (USD) 5 475 257
Average Daily Capital Traded 0,91%
EPS & Dividend